December 4, 2012
COLUMBUS, Ohio – Dr. Clay Marsh, a world-renowned and respected scientist and educator at The Ohio State University College of Medicine, recently received the Distinguished Alumnus Award presented by the West Virginia University School of Medicine Alumni Association. Marsh was honored for a lifetime of merit and outstanding accomplishments with international or national recognition.
Marsh received an undergraduate degree in biology in 1981 and earned his medical degree from West Virginia University in 1985. He completed his residency in internal medicine in 1988 at Ohio State, where he served as chief resident.
The prestigious award was established in 1984 to honor alumni “whose distinguished careers and unselfish contributions to society have enhanced the prestige of West Virginia University School of Medicine and, in their own way, have helped to upgrade the quality of health care.” A candidate must be a graduate of the West Virginia University School of Medicine whose career has been distinguished by scholarly achievement, humanitarian contribution, or outstanding service to the institution.
In 2009, Marsh was appointed by The Ohio State University Board of Trustees as senior associate vice president for research in the Office of Health Sciences, vice dean for research in the College of Medicine and executive director of the OSU Center for Personalized Health Care. Leading The Ohio State University Wexner Medical Center’s pioneering research program, Marsh is also guiding the planning and expansion of the health system’s infinite research endeavors, is responsible for recruitment of key researchers and heads the introduction of advanced technology initiatives to Ohio State’s Wexner Medical Center.
Under Marsh’s executive leadership, Ohio State’s Center for Personalized Health Care is earning international distinction through its leadership in a novel approach to personalized health care known as P4 Medicine – predictive, preventive, personalized and participatory medicine. P4 Medicine focuses on creating systems to deliver health care focused on bringing the right intervention or treatment to the right person at the right time to save money and improve outcomes. P4 Medicine enables the delivery of key evidence-based practices to reduce healthcare costs and improve outcomes, and leverage the interface between an individual’s unique DNA, environment and behavior to promote health and wellness.
In addition, P4 Medicine is focused on reducing the 17 year gap in “discovery to delivery” to move innovations to users in a rapid timeframe. To accomplish this goal, OSU Wexner Medical Center, has embedded entrepreneurs and companies in the P4 Medicine pipeline. Marsh has spearheaded the complementary positioning of successful leaders and entrepreneurs in academia, industry and business, which is key to delivering solutions to those who need them.
With Marsh at the helm, Ohio State is a co-founder, along with the Institute for Systems Biology, of the P4 Medicine Institute, a Seattle based non-profit innovation consortium established in 2010 to lead the transformation of healthcare from a reactive system to one that predicts and prevents disease, tailors diagnosis and therapy to the individual consumer and engages patients in the active pursuit of a quantified understanding of wellness. In addition, Ohio State recently partnered with Allostatix and co-founded P44U, a neural network company focused on creating prediction models and providing interventions to lower healthcare costs.
Marsh, also director of the Center for Critical Care and Respiratory Medicine at the Medical Center, helped elevate the Division of Pulmonary, Allergy, Critical Care and Sleep Medicine to a position of national prominence as its former director.
Marsh has won numerous teaching awards and has been recognized nationally for his research and devotion to teaching and mentorship of medical students, residents and fellows. He has been an invited speaker at various national conferences, has published more than 130 journal articles and book chapters, and holds six U.S. patent applications and 10 international patent applications.
Marsh is a member of several professional organizations including the American Thoracic Society, the American College of Physicians, the American Federation for Medical Research, the American Association for the Advancement of Science, the American Association of Immunologists, the Federation of American Society for Experimental Biology, the Central Society for Clinical Research, the American Society for Biochemistry and Molecular Biology, the American Society for Clinical Investigation, the Society for Critical Care Medicine, the Association of Academic Health Centers, and the American College of Physicians.
He also serves on the board of the Personalized Medicine Coalition and has served as chairman of the board of the Stanley Sarnoff Research Foundation, and as a national leader in pulmonary medicine on the Battelle Bioinitiative in Pulmonary Medicine.
###